[ad_1]
The corporate’s Board additionally authorized the Scheme of Association for amalgamation of 5 subsidiaries into Solar Pharmaceutical and reclassification of normal reserves to retained earnings, topic to crucial approvals.
Pharma main Solar Pharmaceutical Industries Ltd mentioned it closed Q2FY24 with decrease operational income, picture credit score: Reuters
[ad_2]